These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16040128)

  • 1. Effects of candidate vaginally-applied microbicide compounds on innate immune cells.
    Milligan GN; Young CG; Meador MG; Chu CF; Stanberry LR
    J Reprod Immunol; 2005 Aug; 66(2):103-16. PubMed ID: 16040128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of candidate vaginally-applied microbicide compounds on recognition of antigen by CD4+ and CD8+ T lymphocytes.
    Milligan GN; Chu CF; Young CG; Stanberry LR
    Biol Reprod; 2004 Nov; 71(5):1638-45. PubMed ID: 15240422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrageenan formulation prevents macrophage trafficking from vagina: implications for microbicide development.
    Perotti ME; Pirovano A; Phillips DM
    Biol Reprod; 2003 Sep; 69(3):933-9. PubMed ID: 12773428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entry of inflammatory cells into the mouse vagina following application of candidate microbicides: comparison of detergent-based and sulfated polymer-based agents.
    Milligan GN; Dudley KL; Bourne N; Reece A; Stanberry LR
    Sex Transm Dis; 2002 Oct; 29(10):597-605. PubMed ID: 12370527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity.
    Keller MJ; Guzman E; Hazrati E; Kasowitz A; Cheshenko N; Wallenstein S; Cole AL; Cole AM; Profy AT; Wira CR; Hogarty K; Herold BC
    AIDS; 2007 Feb; 21(4):467-76. PubMed ID: 17301565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial.
    Keller MJ; Zerhouni-Layachi B; Cheshenko N; John M; Hogarty K; Kasowitz A; Goldberg CL; Wallenstein S; Profy AT; Klotman ME; Herold BC
    J Infect Dis; 2006 Jan; 193(1):27-35. PubMed ID: 16323128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission.
    Cone RA; Hoen T; Wong X; Abusuwwa R; Anderson DJ; Moench TR
    BMC Infect Dis; 2006 Jun; 6():90. PubMed ID: 16740164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.
    Fichorova RN; Bajpai M; Chandra N; Hsiu JG; Spangler M; Ratnam V; Doncel GF
    Biol Reprod; 2004 Sep; 71(3):761-9. PubMed ID: 15128598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model.
    Spencer SE; Valentin-Bon IE; Whaley K; Jerse AE
    J Infect Dis; 2004 Feb; 189(3):410-9. PubMed ID: 14745698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of cervicovaginal inflammation for the assessment of microbicide safety.
    Cummins JE; Doncel GF
    Sex Transm Dis; 2009 Mar; 36(3 Suppl):S84-91. PubMed ID: 19218890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits.
    Aranha CC; Gupta SM; Reddy KV
    Cytokine; 2008 Jul; 43(1):63-70. PubMed ID: 18513989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model.
    Bourne N; Bernstein DI; Ireland J; Sonderfan AJ; Profy AT; Stanberry LR
    J Infect Dis; 1999 Jul; 180(1):203-5. PubMed ID: 10353881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety.
    Galen BT; Martin AP; Hazrati E; Garin A; Guzman E; Wilson SS; Porter DD; Lira SA; Keller MJ; Herold BC
    J Infect Dis; 2007 May; 195(9):1332-9. PubMed ID: 17397004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse.
    Soboll G; Schaefer TM; Wira CR
    Am J Reprod Immunol; 2006 Jun; 55(6):434-46. PubMed ID: 16674601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbicide offers no protection against HIV infection.
    Roehr B
    BMJ; 2009 Dec; 339():b5538. PubMed ID: 20022912
    [No Abstract]   [Full Text] [Related]  

  • 16. Cervicovaginal evaluation in macaques used as a model for topical microbicide safety studies.
    Scorpio DG; Ruben DS; Liao Z; Hildreth JE; Fletcher CA
    J Med Primatol; 2008 Feb; 37 Suppl 1():65-73. PubMed ID: 18269532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages and resistance to tumours: influence of agents affecting macrophages and delayed-type hypersensitivity on resistance to tumours inducing concomitant immunity.
    Nelson M; Nelson DS
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):211-23. PubMed ID: 209776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
    Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A summary of preclinical topical microbicide vaginal safety and chlamydial efficacy evaluations in a pigtailed macaque model.
    Patton DL; Cosgrove Sweeney YT; Paul KJ
    Sex Transm Dis; 2008 Oct; 35(10):889-97. PubMed ID: 18607310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial to determine the distribution of four topical gel formulations in the human vagina.
    Barnhart K; Kulp JL; Rosen M; Shera DM
    Contraception; 2009 Apr; 79(4):297-303. PubMed ID: 19272499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.